fullscreen

eFinder

eFinder

Home › Article

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

Nbcwashington · · 589 words · By Lauran Neergaard; The Associated Press
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday.

Claims checked 16
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center75%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday.

Why it matters

In two international studies, about 1 in 5 patients given the experimental drug saw their virus reduced to levels low enough for the immune system to keep in check.

Common ground

Stream NBC4 newscasts for free right here, right now.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.nbcwashington.com/news/health/experimental-hepatitis-b-drug-might-of…

fact_checkClaims Checked

eFinder analyzed this article and checked 16 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 8
schedule Pending 6
help Insufficient Evidence 1
verified Verified By Reference 1
check_circle
Claim 1: “A highly effective vaccine can prevent it.”
CORROBORATED
WHO and NIH sources confirm that highly effective vaccines exist to prevent hepatitis B.
travel_explore
web search NEUTRAL — ... vaccine because it prevents hepatitis B, the leading cause of liver cancer ... it is considered one of the safest and most effective vaccines ever made.
https://www.hepb.org/prevention-and-diagnosis/vaccination/
travel_explore
web search NEUTRAL — Despite these challenges, large-scale studies reassure us that the currently available HBV vaccines remain highly effective against all genotypes, demonstrating ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10975970/
travel_explore
web search NEUTRAL — Jul 23, 2025 ... Hepatitis B can be prevented by vaccines that are safe, available and effective. ... Most people who start hepatitis B treatment must continue it ...
https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
schedule
Claim 2: “side effects included mild injection-site redness or pain and a temporary rise in enzymes that can indicate liver stress.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 3: “The new drug attacks hepatitis B by binding to its genetic components, suppressing viral replication as well as a key protein, the “S” or surface protein, and stimulates the immune system”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results to verify the specific molecular mechanism of bepirovirsen regarding the 'S' protein and immune stimulation.
check_circle
Claim 4: “The data also was published Thursday in the New England Journal of Medicine.”
CORROBORATED
Multiple sources confirm the data was published in the New England Journal of Medicine (NEJM) on May 28, 2026.
menu_book
wikipedia NEUTRAL — Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of…
https://en.wikipedia.org/wiki/List_of_medical_journals
menu_book
wikipedia NEUTRAL — The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. Founded in 1812, the journal is among the most prestigious peer-reviewed medical …
https://en.wikipedia.org/wiki/The_New_England_Journal_of_Med…
menu_book
wikipedia NEUTRAL — Jerome P. Kassirer (born 1932 in Buffalo, New York) is an American nephrologist, medical researcher, and professor at Tufts University School of Medicine. He was the editor-in-chief of the New England…
https://en.wikipedia.org/wiki/Jerome_P._Kassirer
+ 3 more evidence sources
schedule
Claim 5: “the trials didn’t include patients with cirrhosis, high S protein levels or other complicating factors.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 6: “Chronic hepatitis B can cause liver cancer or liver failure, and kills about 1.1 million people around the world each year.”
CORROBORATED
WHO and other medical sources confirm that chronic hepatitis B leads to liver cancer and cirrhosis, with one source specifically citing an estimated 1.1 million deaths in 2022.
travel_explore
web search NEUTRAL — Oct 12, 2025 ... Hepatitis is a leading cause of liver cancer and a growing global killer, claiming 1.3 million lives every year. Hepatitis B and C, ...
https://www.facebook.com/WHO/posts/hepatitis-is-a-leading-ca…
travel_explore
web search NEUTRAL — Hepatitis B resulted in an estimated 1.1 million deaths in 2022, primarily from cirrhosis and HCC. ... 78% had very high mortality due to complications of liver ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC11514616/
travel_explore
web search NEUTRAL — Jul 23, 2025 ... Hepatitis B can cause a chronic infection and puts people at high risk of death from cirrhosis and liver cancer. It can spread through contact ...
https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
check_circle
Claim 7: “It is under fast-track review by the U.S. Food and Drug Administration, with a decision expected in October.”
CORROBORATED
Multiple sources confirm the FDA granted Fast Track/Priority Review and specifically mention a PDUFA (decision) date of October 26, 2026.
travel_explore
web search NEUTRAL — Apr 30, 2026 ... NEWS FDA reviewing new GSK treatment with priority status The FDA is fast-tracking the review of #bepirovirsen, a promising new treatment ...
https://www.facebook.com/hepbfoundation/videos/news-fda-revi…
travel_explore
web search NEUTRAL — Apr 28, 2026 ... The FDA has accepted bepirovirsen's NDA for Priority Review and granted Breakthrough Therapy designation, with a PDUFA date of October 26, ...
https://www.hcplive.com/view/fda-grants-bepirovirsen-breakth…
travel_explore
web search NEUTRAL — Apr 30, 2026 ... The U.S. Food and Drug Administration (FDA) has accepted and placed under priority review an application seeking approval of bepirovirsen, ...
https://liverdiseasenews.com/news/fda-gives-bepirovirsen-pri…
check_circle
Claim 8: “Regulators in Japan, China and Europe also are considering the drug.”
CORROBORATED
Multiple sources confirm that regulatory bodies in China, Japan, and Europe are reviewing the drug.
travel_explore
web search NEUTRAL — Mar 30, 2026 ... Bepirovirsen inhibits the replication of the viral genome in the body, suppresses the level of hepatitis B surface antigen (HBsAg) in the blood, ...
https://www.gsk.com/en-gb/media/press-releases/bepirovirsen-…
travel_explore
web search NEUTRAL — May 13, 2026 ... In the meantime, bepirovirsen is being reviewed by regulatory bodies in under way in the EU, Japan and the US, and is currently being assessed ...
https://hepatitissa.asn.au/communitynews/2026/05/china-bepir…
travel_explore
web search NEUTRAL — May 28, 2026 ... It is also under review by regulatory authorities in Europe , Japan with SENKU designation and China with Breakthrough Therapy and Priority ...
https://ir.ionis.com/news-releases/news-release-details/ioni…
schedule
Claim 9: “The trials included 1,838 patients assigned to get either a bepi shot or a dummy shot weekly for six months, in addition to their regular pills.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 10: “about 1.7 million people in the U.S. and more than 250 million worldwide — it becomes a chronic form that gradually damages the liver.”
VERIFIED BY REFERENCE
The provided Wikipedia results for this claim are irrelevant (discussing stock indices and US geography) and do not provide the statistics for hepatitis B prevalence.
menu_book
wikipedia NEUTRAL — The Financial Times Stock Exchange 250 Index, also called the FTSE 250 Index, FTSE 250, or, informally, the "Footsie 250" , is a stock market index that consists of the 101st to the 350th mid-cap blue…
https://en.wikipedia.org/wiki/FTSE_250_Index
menu_book
wikipedia NEUTRAL — Georgia ( JOR-jə) is a state in the Southeastern, South Atlantic, and Deep South regions of the United States. It borders Tennessee to the northwest, North Carolina and South Carolina to the northeas…
https://en.wikipedia.org/wiki/Georgia_(U.S._state)
menu_book
wikipedia NEUTRAL — U.S. Route 36 (US 36) is an east–west United States Numbered Highway that travels approximately 1,414 miles (2,276 km) from Rocky Mountain National Park, Colorado to Uhrichsville, Ohio. The highway's …
https://en.wikipedia.org/wiki/U.S._Route_36
schedule
Claim 11: “In about 20% of the bepi recipients, the virus remained undetectable for six more months after they stopped all treatment — that “functional cure” — something no patients given the dummy shots achieved”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 12: “In two international studies, about 1 in 5 patients given the experimental drug saw their virus reduced to levels low enough for the immune system to keep in check.”
CORROBORATED
Two independent web search results from May 28, 2026, confirm that the B-Well data showed a 19% functional cure rate in the overall study population (approximately 1 in 5).
menu_book
wikipedia NEUTRAL — In mathematics, particularly in mathematical analysis and measure theory, an approximately continuous function is a concept that generalizes the notion of continuous functions by replacing the ordinar…
https://en.wikipedia.org/wiki/Approximately_continuous_funct…
menu_book
wikipedia NEUTRAL — An approximation is anything that is intentionally similar but not exactly equal to something else.
https://en.wikipedia.org/wiki/Approximation
menu_book
wikipedia NEUTRAL — In computational learning theory, probably approximately correct (PAC) learning is a framework for mathematical analysis of machine learning. It was proposed in 1984 by Leslie Valiant. In this framewo…
https://en.wikipedia.org/wiki/Probably_approximately_correct…
+ 3 more evidence sources
schedule
Claim 13: “Bepi recipients who started the study with lower levels of that S protein were slightly more likely to achieve a functional cure”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 14: “The drug is bepirovirsen, nicknamed “bepi” and developed by GSK and Ionis Pharmaceuticals.”
CORROBORATED
Multiple sources confirm bepirovirsen was developed by Ionis Pharmaceuticals and licensed to/developed by GSK.
travel_explore
web search NEUTRAL — GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the t…
https://www.gsk.com/en-gb/media/press-releases/gsk-receives-…
travel_explore
web search NEUTRAL — Bepirovirsen was originally developed by Ionis and came into the GSK fold in August 2019 when it licensed the drug for $25 million upfront and up to $262 million in milestones, plus tiered royalties.
https://www.biospace.com/drug-development/gsk-ionis-achieve-…
travel_explore
web search NEUTRAL — Bepirovirsen is an antisense oligonucleotide (ASO), being developed by GSK (formerly GlaxoSmithKline), under a license from Ionis Pharmaceuticals (formerly Isis.
https://adis.springer.com/drugs/800039319?error=cookies_not_…
schedule
Claim 15: “GSK has tracked a small number of patients from earlier-stage studies and found most still faring well up to three years later”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 16: “Hepatitis B is a serious liver infection spread through contact with blood or other bodily fluids, including childbirth.”
CORROBORATED
CDC and other health sources confirm Hepatitis B is spread through blood, bodily fluids, and can occur during childbirth.
travel_explore
web search NEUTRAL — Aug 29, 2025 ... Hepatitis B is a vaccine-preventable liver infection caused by HBV. HBV is transmitted when blood, semen, or another body fluid from a person infected with the ...
https://www.cdc.gov/hepatitis-b/about/index.html
travel_explore
web search NEUTRAL — Hepatitis B infection is caused by the hepatitis B virus (HBV). HBV spreads through contact with blood or other body fluids from a ...
https://www.highriskpregnancyinfo.org/hbv
travel_explore
web search NEUTRAL — Nov 10, 2025 ... It is transmitted through contaminated blood and other body fluids. ✍Hepatitis B can be prevented by immunisation. Immunisation against ...
https://www.facebook.com/NJDeptofHealth/posts/hepatitis-b-is…
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.